Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Lapatinib Ditosylate, Trastuzumab, Paclitaxel, and Surgery in Treating Patients With Breast Cancer [Phase 2]
Phase 2 trial evaluating lapatinib ditosylate plus trastuzumab, paclitaxel, and surgery for HER2-positive breast cancer completed with resul…
-
CLINICAL_TRIALS trial_result · 2017-09-06Clinical Trial Update: Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer [Phase 2]
Phase 2 trial comparing lapatinib plus chemotherapy to trastuzumab plus chemotherapy in HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers [Phase 2, Phase 3]
Phase 2/3 trial update evaluating optimal duration of pre-operative letrozole and correlation of clinical efficacy with surrogate markers in…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery [Phase 2]
A Phase 2 trial evaluating a multi-drug regimen (doxorubicin hydrochloride, cyclophosphamide, filgrastim) followed by paclitaxel albumin-sta…
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating Bevacizumab plus Letrozole for postmenopausal women with locally advanced or metastatic breast cancer not …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-08-31Clinical Trial Update: FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients [EARLY_Phase 1]
Early-phase trial investigates FACBC PET and PEM as staging tools and indicators of therapeutic response in breast cancer.
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: The CEASE Study: Computer Based Educational Module for the Reduction of Arthralgia Syndrome Associated With Endocrine Therapy for Breast Cancer [NA]
The CEASE study, conducted by George Washington University, evaluated a computer-based educational module to reduce arthralgia syndrome asso…
-
CLINICAL_TRIALS trial_result · 2017-08-30Clinical Trial Update: Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study [NA]
This document provides an update on a clinical trial evaluating the response of metastatic breast cancer to cancer therapies in bone. The as…
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Neoadjuvant Chemotherapy of 6 Cycles vs 8 Cycles in Node Positve Breast Cancer [Phase 3]
A Phase 3 trial comparing six versus eight cycles of neoadjuvant chemotherapy for node-positive breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-08-29Clinical Trial Update: Neoadjuvant Combined Endocrine and HER2 Target Therapy in Postmenopausal Women With ER and Her2 Positive Breast Cancer [Phase 2]
The Phase 2 neoadjuvant trial NCT01275859 evaluating combined endocrine and HER2-targeted therapy in postmenopausal women with ER-positive a…
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Assessment of Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in ER-positive, Her2-negative Early Breast Cancer [NA]
A trial evaluating whether a genomic test influences shared decisions on adjuvant chemotherapy for ER-positive, HER2-negative early breast c…
-
FDA approval · 2017-08-25FDA Approved: FASLODEX — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Faslodex (fulvestrant) from AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms [Phase 3]
Phase 3 trial evaluating prasterone (dehydroepiandrosterone) for vaginal symptoms in postmenopausal cancer survivors has completed with resu…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer [Phase 3]
A Phase 3 trial compares simultaneous versus sequential use of adjuvant chemotherapy and GnRH agonist therapy in ER-positive, premenopausal …
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: MK2206 and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Metastatic Breast Cancer [Phase 1]
Phase 1 study evaluating the AKT inhibitor MK-2206 in combination with Paclitaxel for locally advanced or metastatic solid tumors and metast…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394) [Phase 3]
Phase III trial comparing adjuvant high-dose cyclophosphamide plus doxorubicin (AC) versus sequential doxorubicin followed by cyclophosphami…
-
CLINICAL_TRIALS trial_result · 2017-08-25Clinical Trial Update: A Pilot Study of Varying Doses of Tamoxifen in the Setting of Genetic Polymorphisms of CYP2D6
A pilot study evaluating varying doses of tamoxifen in breast cancer patients with respect to CYP2D6 genetic polymorphisms.
-
CLINICAL_TRIALS research · 2017-08-25Clinical Trial Update: An Observational Study of Avastin (Bevacizumab) in Combination With Paclitaxel in First-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer
This document reports the completion of an observational study evaluating Avastin (bevacizumab) in combination with paclitaxel as first-line…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases [Phase 3]
Phase 3 trial evaluating stereotactic radiation therapy with or without whole-brain radiation therapy for brain metastases; completed with r…
-
CLINICAL_TRIALS trial_result · 2017-08-24Clinical Trial Update: Intra-operative Digital vs. Standard Mammography [Phase 4]
Phase 4 trial comparing intra-operative digital mammography to standard mammography in breast cancer has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-08-23Clinical Trial Update: Assessment of TK006 in Patients With Breast Cancer-related Bone Metastases [Phase 1]
Phase 1 trial update for TK006 in breast cancer with bone metastases; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-08-22Clinical Trial Update: Neoadjuvant Carboplatin, Weekly Abraxane and Trastuzumab in HER2+ Breast Cancer [Phase 2]
Phase 2 trial update on neoadjuvant carboplatin with weekly Abraxane and trastuzumab in HER2-positive breast cancer.
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Electric Stimulation on Nausea and Vomit Chemotherapy Induced [NA]
Clinical trial update investigating electrical stimulation to reduce chemotherapy-induced nausea and vomiting in breast cancer patients. Spo…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Effect of a Tailored Program of Physical Activity and Nutritional Counseling on Fatigue Reduction in Breast Cancer Patients Receiving an Adjuvant Treatment [Phase 3]
A Phase 3 trial evaluated whether a tailored program of physical activity and nutritional counseling reduces fatigue in breast cancer patien…
-
CLINICAL_TRIALS trial_result · 2017-08-21Clinical Trial Update: Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN) [NA]
This clinical trial update describes the IDEA SEIN study, which aims to identify and evaluate biomarkers of resistance to neoadjuvant chemot…